CH681300A5 - - Google Patents

Download PDF

Info

Publication number
CH681300A5
CH681300A5 CH1348/90A CH134890A CH681300A5 CH 681300 A5 CH681300 A5 CH 681300A5 CH 1348/90 A CH1348/90 A CH 1348/90A CH 134890 A CH134890 A CH 134890A CH 681300 A5 CH681300 A5 CH 681300A5
Authority
CH
Switzerland
Prior art keywords
general formula
lower alkyl
compound
reaction
carried out
Prior art date
Application number
CH1348/90A
Other languages
German (de)
English (en)
Inventor
Jozsef Dr Reiter
Laszlo Dr Pongo
Frigyes Dr Goergenyi
Marton Dr Fekete
Margit Dr Csoergo
Ilona Dr Sztuhar
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU193189A external-priority patent/HU203342B/hu
Priority claimed from HU193089A external-priority patent/HU203333B/hu
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CH681300A5 publication Critical patent/CH681300A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1348/90A 1989-04-21 1990-04-20 CH681300A5 (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU193189A HU203342B (en) 1989-04-21 1989-04-21 Process for producing quinazoline deivatives
HU193089A HU203333B (en) 1989-04-21 1989-04-21 Process for producing n-cyano-carboxamidine derivatives

Publications (1)

Publication Number Publication Date
CH681300A5 true CH681300A5 (lv) 1993-02-26

Family

ID=26317437

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1348/90A CH681300A5 (lv) 1989-04-21 1990-04-20

Country Status (16)

Country Link
JP (1) JPH02292282A (lv)
KR (1) KR900016194A (lv)
AT (1) AT398075B (lv)
BG (1) BG91821A (lv)
CA (2) CA2015066A1 (lv)
CH (1) CH681300A5 (lv)
DK (1) DK99090A (lv)
ES (1) ES2019826A6 (lv)
FI (1) FI902002A0 (lv)
GB (1) GB2231571B (lv)
GR (1) GR900100294A (lv)
IT (1) IT1241128B (lv)
PL (1) PL162976B1 (lv)
RU (1) RU1838309C (lv)
SE (1) SE9001402L (lv)
YU (1) YU70890A (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2077252C (en) * 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
ES2096518B1 (es) * 1994-03-28 1997-12-01 Grupo Farmaceutico Almirall S Nuevas anilinas.
WO2008015525A2 (en) * 2006-07-31 2008-02-07 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of alfuzosin hydrochloride
EP2152697A2 (en) 2007-05-04 2010-02-17 Actavis Group PTC EHF Process for the preparation of alfuzosin and salts thereof
AU2008281567B2 (en) 2007-08-02 2012-07-26 Cipla Limited Process for the preparation of alfuzosin hydrochloride

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4044135A (en) * 1975-10-14 1977-08-23 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
FI56836C (fi) * 1977-10-25 1980-04-10 Fermion Oy 4-substituerade piperazin-1-(n-aryl-n'-cyano)-karboximidamider som aer mellanprodukter vid framstaellningen av farmakologiskt vaerdefulla 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner
FI57751C (fi) * 1977-10-25 1980-10-10 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner med blodtryckssaenkande verkan
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
FI59800C (fi) * 1979-01-10 1981-10-12 Fermion Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(furo-2-yl)-piperazin-1-yl)-kinazolin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
EP0146642B1 (de) * 1983-11-22 1988-01-20 LUDWIG HEUMANN & CO GMBH Verfahren zur Herstellung von 4-Amino-6,7-dimethoxy-2-(4-(furo-2-yl)-piperazin-1-yl)-chinazolin und dessen physiologisch annehmbarer Salze

Also Published As

Publication number Publication date
FI902002A0 (fi) 1990-04-20
IT9020092A0 (it) 1990-04-20
IT9020092A1 (it) 1991-10-20
SE9001402D0 (sv) 1990-04-20
IT1241128B (it) 1993-12-29
DK99090A (da) 1990-10-22
BG91821A (bg) 1993-12-24
ES2019826A6 (es) 1991-07-01
JPH02292282A (ja) 1990-12-03
PL162976B1 (pl) 1994-01-31
ATA93190A (de) 1994-01-15
SE9001402L (sv) 1990-10-22
DK99090D0 (da) 1990-04-20
YU70890A (en) 1992-05-28
RU1838309C (ru) 1993-08-30
GB2231571A (en) 1990-11-21
KR900016194A (ko) 1990-11-12
CA2015066A1 (en) 1990-10-21
GB9008941D0 (en) 1990-06-20
GR900100294A (el) 1991-09-27
CA2028953A1 (en) 1990-10-22
PL284860A1 (en) 1991-03-11
GB2231571B (en) 1992-09-16
AT398075B (de) 1994-09-26

Similar Documents

Publication Publication Date Title
RU2096411C1 (ru) Производные бензимидазолона, смеси их изомеров или их кислотно-аддитивные соли в качестве антагониста рецептора 5-ht*00i*00a и 5-нт*002
DE69723846T2 (de) Verfahren zur Herstellung von Sildenafil
Tani et al. Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4 (3H)-quinazolinone derivatives
EP0726899B1 (de) Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln
EP0006506B1 (de) 1,2-Dihydro-chinolin-2-on-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE1231705B (de) Verfahren zur Herstellung von 2, 3-substituierten Chinazolon-(4)-derivaten
DE2238628A1 (de) Verfahren zur herstellung von furanverbindungen
DE1620035A1 (de) 3-Amino-5-X-6-halogenpyrazinonitrile und Verfahren zu deren Herstellung
JPH07188207A (ja) 1−[2h−1−ベンゾピラン−2−オン−8−イル]−ピペラジン誘導体
DD286581A5 (de) Verfahren zur herstellung von hetera-aliphatischem carbonsaeureamiden
DE69411589T2 (de) Indol, indolin und chinolin derivate mit einer 5ht1d antagonistischen wirkung
CH681300A5 (lv)
DE2508543A1 (de) Verfahren zur herstellung von imidazo- und pyrimido eckige klammer auf 2,1-b eckige klammer zu -chinazolinen und neue chinazoline
US3200151A (en) Arylaminoalkyl guanidines
DE2413610A1 (de) Neue heterocyclische verbindungen und verfahren zu deren herstellung
CS202069B2 (en) Method of preparing 2-/4-substituted piperazine-1-yl/-4-amino-6,7-dimethoxyquinazolines
DE1076691B (de) Verfahren zur Herstellung von Phenthiazinderivaten
EP0472166A1 (de) Tricyclische Pyridonderivate
EP0552758A1 (de) N-5-geschützte 2,5-Diamino-4,6-dichlorpyrimidine und Verfahren zu deren Herstellung
DE2903850A1 (de) 2-amino-8-cyclopropyl-5-oxo-5,8- dihydro-pyrido eckige klammer auf 2,3-d eckige klammer zu -pyrimidin-6-carnonsaeuren, verfahren zu ihrer herstellung sowie ihrer verwendung als antibakterielle mittel
DE69230730T2 (de) VERFAHREN ZUR HERSTELLUNG VON BENZO[b]NAPHTHYRIDINEN
DD297971A5 (de) Verfahren zur herstellung von chinazolinderivaten
SU999967A3 (ru) Способ получени 6-N-замещенных 6-амино-3-пиридазинилгидразинов или их солей
AU689478B2 (en) Pharmacologically active enantiomers of triazolone compounds
NO129744B (lv)

Legal Events

Date Code Title Description
PL Patent ceased